Press releases

Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine

June 23, 2022

WILMINGTON, Mass. and GHENT, Belgium - Charles River Laboratories International, Inc. (NYSE: CRL) and Ziphius Vaccines today announced an agreement to manufacture starting materials critical to clinical-stage research.

News

Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics

June 9, 2022

News

Ziphius Vaccines and Ghent University Publish Promising Data from self-amplifying RNA Platform in Molecular Therapy

May 6, 2022

Upcoming

There are no upcoming events at this time.

Past

13 -16
June

BIO International Convention

San Diego

24 -26
May

Next Generation mRNA Therapeutics Summit

Boston

10 -11
May

LSX World Congress

London

Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine

Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics

Ziphius Vaccines and Ghent University Publish Promising Data from self-amplifying RNA Platform in Molecular Therapy

Events

Upcoming

Past